MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 6 (2009), Issue 9 (September)

1. The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections.
   J Craniomaxillofac Surg, 37(7): 392-7. [Abstract] [Full-text]
2. Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria.
   J Clin Microbiol, 47(9): 2975-80. [Abstract] [Full-text]
3. BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.
   J Clin Microbiol, 47(9): 2879-82. [Abstract] [Full-text]
4. Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan.
   J Clin Microbiol, 47(9): 2957-63. [Abstract] [Full-text]
5. Cooccurrence of predominant Panton-Valentine leukocidin-positive sequence type (ST) 152 and multidrug-resistant ST 241 Staphylococcus aureus clones in Nigerian hospitals.
   J Clin Microbiol, 47(9): 3000-3. [Abstract] [Full-text]
6. Antibiotic resistance and genetic diversity in Staphylococcus aureus from slaughter pigs in Switzerland.
   Schweiz Arch Tierheilkd, 151(9): 425-31. [Abstract] [Full-text]
7. An investigation of methicillin-resistant Staphylococcus aureus colonization in people and pets in the same household with an infected person or infected pet.
   J Am Vet Med Assoc, 235(5): 540-3. [Abstract] [Full-text]
8. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
   Antimicrob Agents Chemother, 53(9): 3880-6. [Abstract] [Full-text]
9. Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.
   Antimicrob Agents Chemother, 53(9): 3635-41. [Abstract] [Full-text]
10. In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs.
    Antimicrob Agents Chemother, 53(9): 3620-7. [Abstract] [Full-text]
11. Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
    Antimicrob Agents Chemother, 53(9): 3642-9. [Abstract] [Full-text]
12. Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia.
    Antimicrob Agents Chemother, 53(9): 3894-901. [Abstract] [Full-text]
13. In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
    Antimicrob Agents Chemother, 53(9): 3777-81. [Abstract] [Full-text]
14. Xanthoradones, new potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2: I. Taxonomy, fermentation, isolation and biological properties.
    J Antibiot (Tokyo), 62(8): 431-4. [Abstract] [Full-text]
15. Xanthoradones, new potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2 II. Structure elucidation.
    J Antibiot (Tokyo), 62(8): 435-7. [Abstract] [Full-text]
16. Imaging of pediatric musculoskeletal infection.
    Semin Musculoskelet Radiol, 13(3): 277-99. [Abstract] [Full-text]
17. Efficacy of Besifloxacin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Keratitis.
    Cornea. [Abstract] [Full-text]
18. VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth.
    Antimicrob Agents Chemother, 53(9): 3657-63. [Abstract] [Full-text]
19. Typing of staphylococcal cassette chromosome mec encoding methicillin resistance in Staphylococcus aureus strains isolated at the bone marrow transplant centre of Tunisia.
    Curr Microbiol, 59(4): 380-5. [Abstract] [Full-text]
20. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.
    J Clin Invest, 119(9): 2464-74. [Abstract] [Full-text]
21. Duration of antibiotic therapy for ventilator-associated pneumonia in burn patients.
    J Burn Care Res, 30(5): 801-6. [Abstract] [Full-text]
22. Control of MRSA infection and colonisation in an intensive care unit by GeneOhm MRSA assay and culture methods.
    BMC Infect Dis, 9: 137. [Abstract] [Full-text]
23. Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.
    Expert Rev Anti Infect Ther, 7(7): 777-91. [Abstract] [Full-text]
24. New treatments for methicillin-resistant Staphylococcus aureus.
    Curr Opin Crit Care, 15(5): 403-12. [Abstract] [Full-text]
25. Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.
    J Antimicrob Chemother, 64(4): 829-36. [Abstract] [Full-text]
26. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Clin Infect Dis, 49(7): 1072-9. [Abstract] [Full-text]
27. Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population.
    Clin Infect Dis, 49(7): 1009-15. [Abstract] [Full-text]
28. Panton-Valentine leukocidin is associated with exacerbated skin manifestations and inflammatory response in children with community-associated staphylococcal scarlet fever.
    Clin Infect Dis, 49(7): e69-75. [Abstract] [Full-text]
29. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Clin Infect Dis, 49(7): 997-1005. [Abstract] [Full-text]
30. Population dynamics of methicillin-susceptible and -resistant Staphylococcus aureus in remote communities.
    J Antimicrob Chemother, 64(4): 684-93. [Abstract] [Full-text]
31. Isolation and characterization of methicillin-resistant Staphylococcus aureus from swine and workers in China.
    J Antimicrob Chemother, 64(4): 680-3. [Abstract] [Full-text]
32. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia.
    Medicine (Baltimore), 88(5): 263-7. [Abstract] [Full-text]
33. Epidemiology of methicillin-resistant Staphylococcus aureus in a university medical center day care facility.
    Infect Control Hosp Epidemiol, 30(10): 985-92. [Abstract] [Full-text]
34. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands.
    Infect Control Hosp Epidemiol, 30(10): 977-84. [Abstract] [Full-text]
35. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.
    J Invest Dermatol, 129(10): 2463-9. [Abstract] [Full-text]
36. Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing meticillin-resistant Staphylococcus aureus in a French university hospital.
    J Med Microbiol, 58: 1337-42. [Abstract] [Full-text]
37. Nationwide epidemiological study revealed the dissemination of meticillin-resistant Staphylococcus aureus carrying a specific set of virulence-associated genes in Japanese hospitals.
    J Med Microbiol, 58: 1329-36. [Abstract] [Full-text]
38. Two variants of staphylococcal cassette chromosome mec type IVA in community-associated meticillin-resistant Staphylococcus aureus strains in South Korea.
    J Med Microbiol, 58: 1314-21. [Abstract] [Full-text]
39. Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activity.
    Biomacromolecules, 10(9): 2592-600. [Abstract] [Full-text]
40. Community-acquired methicillin-resistant Staphylococcus aureus as a cause of rapidly progressing pyelonephritis with pyonephrosis, necessitating emergent nephrectomy.
    Am J Med Sci, 338(3): 233-5. [Abstract] [Full-text]
41. Community-associated MRSA in the United Kingdom.
    J Infect, 59(3): 149-55. [Abstract] [Full-text]
42. Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan.
    J Infect, 59(3): 194-200. [Abstract] [Full-text]
43. Integrative and sequence characteristics of a novel genetic element, ICE6013, in Staphylococcus aureus.
    J Bacteriol, 191(19): 5964-75. [Abstract] [Full-text]
44. Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan.
    Diagn Microbiol Infect Dis, 65(2): 199-201. [Abstract] [Full-text]
45. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Diagn Microbiol Infect Dis, 65(2): 158-62. [Abstract] [Full-text]
46. The Staphylococcus aureus lineage-specific markers collagen adhesin and toxic shock syndrome toxin 1 distinguish multilocus sequence typing clonal complexes within spa clonal complexes.
    Diagn Microbiol Infect Dis, 65(2): 116-22. [Abstract] [Full-text]
47. Evaluation of the Copan ESwab transport system for the detection of methicillin-resistant Staphylococcus aureus: a laboratory and clinical study.
    Diagn Microbiol Infect Dis, 65(2): 108-11. [Abstract] [Full-text]
48. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin.
    J Control Release, 139(2): 118-26. [Abstract] [Full-text]
49. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Int J Antimicrob Agents, 34(5): 395-401. [Abstract] [Full-text]
50. Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection.
    Int J Antimicrob Agents, 34(5): 477-81. [Abstract] [Full-text]
51. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones.
    Int J Antimicrob Agents, 34(5): 424-8. [Abstract] [Full-text]
52. Comparative genomic analysis of European and Middle Eastern community-associated methicillin-resistant Staphylococcus aureus (CC80:ST80-IV) isolates by high-density microarray.
    Clin Microbiol Infect, 15(8): 748-55. [Abstract] [Full-text]
53. The molecular epidemiology and evolution of the Panton-Valentine leukocidin-positive, methicillin-resistant Staphylococcus aureus strain USA300 in Western Australia.
    Clin Microbiol Infect, 15(8): 770-6. [Abstract] [Full-text]
54. Performance of Oxoid Brilliance MRSA medium for detection of methicillin-resistant Staphylococcus aureus: an in vitro study.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
55. Identification of the clonal complexes of Staphylococcus aureus strains by determination of the conservation patterns of small genomic islets.
    J Appl Microbiol, 107(4): 1367-74. [Abstract] [Full-text]
56. Improved hospital-level risk adjustment for surveillance of healthcare-associated bloodstream infections: a retrospective cohort study.
    BMC Infect Dis, 9: 145. [Abstract] [Full-text]
57. Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis.
    Jpn J Ophthalmol, 53(4): 420-4. [Abstract] [Full-text]
58. Short communication: methicillin-resistant Staphylococcus aureus detection in US bulk tank milk.
    J Dairy Sci, 92(10): 4988-91. [Abstract] [Full-text]
59. Future gazing in the management of multiply drug-resistant Gram-positive infection.
    J Infect, 59: S75-80. [Abstract] [Full-text]
60. Linezolid: a review of safety and tolerability.
    J Infect, 59: S59-74. [Abstract] [Full-text]
61. Health economic issues in the treatment of drug-resistant serious Gram-positive infections.
    J Infect, 59: S40-50. [Abstract] [Full-text]
62. Infections caused by Gram-positive bacteria: a review of the global challenge.
    J Infect, 59: S4-16. [Abstract] [Full-text]
63. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
    J Infect, 59: S32-9. [Abstract] [Full-text]
64. Treatment options for nosocomial pneumonia due to MRSA.
    J Infect, 59: S25-31. [Abstract] [Full-text]
65. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
    J Infect, 59: S17-24. [Abstract] [Full-text]
66. Treatment of MRSA infections in an African-American male with G6PD deficiency.
    J Emerg Med, 37(3): 273-8. [Abstract] [Full-text]
67. Differential expression of ccrA in methicillin-resistant Staphylococcus aureus strains carrying staphylococcal cassette chromosome mec type II and IVa elements.
    Antimicrob Agents Chemother, 53(10): 4556-8. [Abstract] [Full-text]
68. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Burns, 35(7): 949-55. [Abstract] [Full-text]
69. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(10): 4252-7. [Abstract] [Full-text]
70. Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.
    Antimicrob Agents Chemother, 53(10): 4127-32. [Abstract] [Full-text]
71. In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(10): 4495-7. [Abstract] [Full-text]
72. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
    Antimicrob Agents Chemother, 53(10): 4217-24. [Abstract] [Full-text]
73. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(10): 4172-7. [Abstract] [Full-text]
74. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.
    Antimicrob Agents Chemother, 53(10): 4264-9. [Abstract] [Full-text]
75. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa.
    J Refract Surg, 25(9): S799-802. [Abstract] [Full-text]
76. Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients.
    BMC Microbiol, 9: 189. [Abstract] [Full-text]
77. Reconstruction of an infected recurrent ventral hernia after a mesh repair using a pedicled tensor fascia lata flap: report of two cases.
    Surg Today, 39(9): 811-7. [Abstract] [Full-text]
78. Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis.
    PLoS One, 4(9): e7204. [Abstract] [Full-text]
79. Harvest surgical site infection following coronary artery bypass grafting: risk factors, microbiology, and outcomes.
    Am J Infect Control, 37(8): 653-7. [Abstract] [Full-text]
80. Evaluation of isolation procedures and chromogenic agar media for the detection of MRSA in nasal swabs from pigs and veal calves.
    Vet Microbiol, 139(1): 121-5. [Abstract] [Full-text]
81. In vitro evaluation of the antimicrobial activity of HM-242, a novel antiseptic compound.
    J Antibiot (Tokyo), 62(9): 489-93. [Abstract] [Full-text]
82. Microbial growth and quorum sensing antagonist activities of herbal plants extracts.
    Molecules, 14(9): 3425-35. [Abstract] [Full-text]
83. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Clin Infect Dis, 49(8): 1169-74. [Abstract] [Full-text]
84. Polyurethane-based leukocyte-inspired biocidal materials.
    Biomaterials, 30(33): 6522-9. [Abstract] [Full-text]
85. Detection of Staphylococcus aureus including MRSA on environmental surfaces in a jail setting.
    J Correct Health Care, 15(4): 310-7. [Abstract] [Full-text]
86. MRSA prevention and control in county correctional facilities in Southwestern Ohio.
    J Correct Health Care, 15(4): 268-79. [Abstract] [Full-text]
87. Disinfection of football protective equipment using chlorine dioxide produced by the ICA TriNova system.
    BMC Public Health, 9: 326. [Abstract] [Full-text]
88. Twelve hundred abscesses operatively drained: an antibiotic conundrum?
    Surgery, 146(4): 794-8; discussion 798-800. [Abstract] [Full-text]
89. DNA sequence detection using surface-enhanced resonance Raman spectroscopy in a homogeneous multiplexed assay.
    Anal Chem, 81(19): 8134-40. [Abstract] [Full-text]
90. Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms.
    Pediatr Pulmonol, 44(10): 970-80. [Abstract] [Full-text]
91. Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategies.
    Am J Obstet Gynecol, 201(4): 396.e1-5. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.